1. Home
  2. GKOS vs UGP Comparison

GKOS vs UGP Comparison

Compare GKOS & UGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$116.17

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Logo Ultrapar Participacoes S.A.

UGP

Ultrapar Participacoes S.A.

HOLD

Current Price

$5.25

Market Cap

5.3B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
UGP
Founded
1998
1937
Country
US
US
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Oil/Gas Transmission
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.3B
IPO Year
2015
2001

Fundamental Metrics

Financial Performance
Metric
GKOS
UGP
Price
$116.17
$5.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
1
Target Price
$133.07
$4.50
AVG Volume (30 Days)
770.3K
2.1M
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
4.05%
EPS Growth
0.36
N/A
EPS
N/A
N/A
Revenue
$383,481,000.00
N/A
Revenue This Year
$23.29
$6.35
Revenue Next Year
$27.74
N/A
P/E Ratio
N/A
$9.99
Revenue Growth
21.85
N/A
52 Week Low
$73.16
$2.64
52 Week High
$142.50
$5.30

Technical Indicators

Market Signals
Indicator
GKOS
UGP
Relative Strength Index (RSI) 52.32 76.64
Support Level $103.55 $5.01
Resistance Level $121.70 $5.30
Average True Range (ATR) 5.70 0.11
MACD -0.23 -0.01
Stochastic Oscillator 63.83 92.04

Price Performance

Historical Comparison
GKOS
UGP

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About UGP Ultrapar Participacoes S.A.

Ultrapar Participacoes SA engages in the investment of its own capital in services, commercial, and industrial activities, through the subscription or acquisition of shares of other companies. The Company has three business segments: Ultragaz distributes LPG in the segments: bulk, comprising condominiums, trade, services, industries, and agribusiness; and bottled, mainly comprising residential consumers. The Ipiranga engages in the distribution and sale of oil-related products, biofuels, and similar products to service stations that operate under the Ipiranga brand throughout Brazil and to consumers and carrier-reseller-retailer. The Ultracargo operates in specialized liquid bulk storage solutions in the main logistics centers of Brazil.

Share on Social Networks: